Article info

Original research
SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report

Authors

  • Kevin Owen McNerney Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St Petersburg, Florida, USAOncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Rebecca M Richards Hematology, Oncology, and Bone Marrow Transplant, University of Wisconsin-Madison, Madison, Wisconsin, USA PubMed articlesGoogle scholar articles
  • Paibel Aguayo-Hiraldo Cancer and Blood Disease Institute, Keck School of Medicine of USC, Los Angeles, California, USA PubMed articlesGoogle scholar articles
  • Friso G Calkoen Division of Pediatric Oncology, Princess Maxima Center, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Julie-An Talano Division of Hematology/Oncology/Blood and Marrow TransplantationDepartment of Pediatrics, Medical College of Wisconsin and Children’s Wisconsin, Milwaukee, Wisconsin, USA PubMed articlesGoogle scholar articles
  • Amy Moskop Division of Hematology/Oncology/Blood and Marrow TransplantationDepartment of Pediatrics, Medical College of Wisconsin and Children’s Wisconsin, Milwaukee, Wisconsin, USA PubMed articlesGoogle scholar articles
  • Adriana Balduzzi Clinica Pediatrica Università degli Studi di Milano Bicocca, Fondazione IRCCS San Gerardo dai Tintori, Milan, Italy PubMed articlesGoogle scholar articles
  • Jennifer Krajewski Pediatric Blood and Marrow Transplantation, Hackensack Meridian School of Medicine, Hackensack, New Jersey, USA PubMed articlesGoogle scholar articles
  • Hema Dave Cancer Immunology and Microbial Oncology Research Program, Children's National Hospital, Washington, District of Columbia, USA PubMed articlesGoogle scholar articles
  • Anant Vatsayan Center for Cancer and Blood Disorders, Children's National Hospital, Washington, District of Columbia, USA PubMed articlesGoogle scholar articles
  • Colleen Callahan Division of Oncology and Cancer Immunotherapy Program, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA PubMed articlesGoogle scholar articles
  • Hongyan Liu Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USADepartment of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA PubMed articlesGoogle scholar articles
  • Yimei Li Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USADepartment of Pediatrics, University of Pennsylvania, Philadelphia, Pennsylvania, USA PubMed articlesGoogle scholar articles
  • Kara Lynn Davis Pediatrics, Stanford University School of Medicine, Stanford, California, USACenter for Cancer Cell Therapy, Stanford Cancer Institute, Stanford, California, USA PubMed articlesGoogle scholar articles
  • Shannon L Maude Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USADivision of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Kevin Owen McNerney; kmcnern1{at}jhmi.edu
View Full Text

Citation

McNerney KO, Richards RM, Aguayo-Hiraldo P, et al
SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report

Publication history

  • Accepted January 6, 2023
  • First published January 27, 2023.
Online issue publication 
December 07, 2023
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.